Matrixyl vs SNAP-8
A side-by-side research comparison of Matrixyl and SNAP-8 across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Matrixyl | SNAP-8 |
|---|---|---|
| Full name | Matrixyl (Palmitoyl Pentapeptide-4 / Pal-KTTKS) | SNAP-8 (Acetyl Octapeptide-3) |
| Category | Skin & Anti-Aging | Skin & Anti-Aging |
| Status | Research compound | Research compound |
| Mechanism | Signals through TGF-B pathway to stimulate fibroblast production of collagen I, III, IV, fibronectin, and hyaluronic acid. Palmitoyl chain enhances penetration. | More effectively competes with SNAP-25 for SNARE complex incorporation due to longer sequence, providing greater vesicle-membrane fusion inhibition. |
| Molecular weight | 802.1 Da | 1,075 Da |
| Half-life | 6-12 hours (topical depot) | 8-14 hours (topical) |
| Bioavailability | Moderate (topical) | Moderate (topical) |
| Typical dose | 2-8% in serum/cream | 3-10% solution |
| Frequency | 1-2x daily | 2x daily |
| Route | Topical | Topical |
Matrixyl reported benefits
- Stimulates collagen I, III, IV
- Reduces wrinkle depth up to 45%
- Increases skin thickness
- Improves firmness
- Enhances hydration
SNAP-8 reported benefits
- Superior to argireline
- Deeper wrinkle reduction
- Prevents expression lines
- Good skin penetration
Related comparisons
Research and educational reference only. Not medical advice.